This book highlights the triumph of MALDI-TOF mass spectrometry over the past decade and provides insight into new and expanding technologies through a comprehensive range of short chapters that enable the reader to gauge their current status and how they may progress over the next decade. This book serves as a platform to consolidate current strengths of the technology and highlight new frontiers in tandem MS/MS that are likely to eventually supersede MALDI-TOF MS. Chapters discuss:
Challenges of Identifying Mycobacterium to the Species level
Identification of Bacteroides and Other Clinically Relevant Anaerobes
Identification of Species in Mixed Microbial Populations
Detection of Resistance Mechanisms
Proteomics as a biomarker discovery and validation platform
Determination of Antimicrobial Resistance using Tandem Mass Spectrometry
Haroun N. Shah Department of Natural Sciences, Middlesex University, London, UK
Saheer E. Gharbia Genomic Research, Public Health England, London, UK
This book highlights the triumph of MALDI-TOF mass spectrometry over the past decade and provides insight into new and expanding technologies through a comprehensive range of short chapters that enable the reader to gauge their current status and how they may progress over the next decade. This book serves as a platform to consolidate current strengths of the technology and highlight new frontiers in tandem MS/MS that are likely to eventually supersede MALDI-TOF MS. Chapters discuss:Challenges of Identifying Mycobacterium to the Species level Identification of Bacteroides and Other Clinically Relevant AnaerobesIdentification of Species in Mixed Microbial PopulationsDetection of Resistance MechanismsProteomics as a biomarker discovery and validation platformDetermination of Antimicrobial Resistance using Tandem Mass Spectrometry
EDITORS Haroun N. Shah, Department of Natural Sciences, Middlesex University, London, UK Saheer E. Gharbia, Genomic Research, Public Health England, London, UK
List of Contributors
Mariann Ábrók
Institute of Clinical Microbiology Faculty of Medicine
University of Szeged
Hungary
Nadia Ahmod
Proteomics Research
Public Health England
London
UK
David J. Allen
Virology
Public Health England
London
UK
Jean Armengaud
CEA‐Marcoule, DSV/IBITEC‐S/SPI/Li2D
Laboratory “Innovative Technologies for Detection and Diagnostics”
Bagnols‐sur‐Cèze
France
Maud Arsac
bioMérieux SA
Marcy‐l’Etoile
France
Peter S. Borriello
Veterinary Medicines Directorate
Surrey
UK
Fredrik Boulund
Department of Mathematical Sciences
Chalmers University of Technology
Gothenburg
Sweden
Patrick Broyer
bioMérieux SA
Marcy‐l’Etoile
France
Irene Burckhardt
Division of Medical Microbiology and Hygiene, Department of Infectious Diseases
University Hospital Heidelberg
Germany
Valeria Calvaresi
Structural Mass Spectrometry and Proteomics Unit
Institut Pasteur
Paris,
France
Timothy Chambers
Proteomics Research
Public Health England
London
UK
Julia Chamot‐Rooke
Structural Mass Spectrometry and Proteomics Unit
Institut Pasteur
Paris
France
Marie‐Hélène Charles
bioMérieux SA
Marcy‐l’Etoile
France
Sonia Chatellier
bioMérieux SA
La Balme‐les‐Grottes
France
Caroline H. Chilton
Leeds Institute for Biomedical and Clinical Sciences
University of Leeds
UK
Song Lin Chua
Singapore Centre for
Environmental Life Sciences Engineering (SCELSE)
and
Lee Kong Chian School of Medicine
Nanyang Technological UniversitySingapore
Arnaldo Colombo
Department of Medicine Infectious Diseases Section
Federal University of São Paulo (UNIFESP)
SP
Brazil
Renata Culak
Proteomics Research
Public Health England
London
UK
Ronald R. Cutler
School of Biological and Chemical Sciences
Queen Mary University of London
UK
Katrien De Bruyne
Applied Maths NV
Sint‐Martens Latem
Belgium
Willem M. de Vos
Faculty of Veterinary Medicine
University of Helsinki
Finland
and
Laboratory of Microbiology
Wageningen University
The Netherlands
Itaru Dekio
Medical Centre East
Tokyo Women’s Medical University
Japan
Magalie Duchateau
Structural Mass Spectrometry and Proteomics Unit
Institut Pasteur
Paris
France
Mathieu Dupré
Structural Mass Spectrometry and Proteomics Unit
Institut Pasteur
Paris
France
Min Fang
Proteomics Research
Public Health England
London
UK
Mark A. Fisher
University of Utah School of Medicine
and
Bacteriology and Antimicrobials
ARUP Infectious Diseases Laboratory
Salt Lake City, UT, USA
Elaine Francisco
Department of Medicine Infectious Diseases Section
Federal University of São Paulo (UNIFESP)
SP
Brazil
Joseph Gault
Structural Mass Spectrometry and Proteomics Unit
Institut Pasteur
Paris
France
Tom Gaulton
Proteomics Research
Public Health England
London
UK
Saheer E. Gharbia
Genomic Research Unit
Public Health England
London
UK
Victoria Girard
bioMérieux SA
La Balme‐les‐Grottes
France
Lucia Gonzales‐Siles
Department of Infectious Diseases
Institute of Biomedicine
The Sahlgrenska Academy
University of Gothenburg
Sweden
Gilbert Greub
Institute of Microbiology, University
Hospital Center, and University of
Lausanne
Switzerland
Nicola Hennessy
Genomic Research Unit
Public Health England
London
UK
Jenny Ho
ThermoFisher Scientific
Hemel Hempstead
Hertfordshire
UK
Christiane Honisch
Illumina, Inc.
San Diego, CA
USA
Martin Hornshaw
ThermoFisher Scientific
Hemel Hempstead
Hertfordshire
UK
Jay Hyman
bioMérieux Inc
Durham, NC
USA
Axel Karger
Friedrich‐Loeffler‐Institut
Federal Research Institute for Animal Health
Greifswald – Insel Riems
Germany
Anders Karlsson
Nanoxis Consulting AB
Gothenburg
Sweden
Roger Karlsson
Department of Clinical Microbiology
Sahlgrenska University Hospital
and
Nanoxis Consulting AB
Gothenburg
Sweden
Jae‐Seok Kim
Department of Laboratory Medicine
Hallym University College of Medicine
Seoul
Korea
Yangsun Kim
ASTA Inc
Gyeonggi‐do
Korea
Carolin Kolmeder
Faculty of Veterinary Medicine
University of Helsinki
Finland
Markus Kostrzewa
Bruker Daltonik GmbH
Bremen
Germany
Annika Kotovuori
ThermoFisher Scientific
Vantaa
Finland
Erik Kristiansson
Department of Mathematical Sciences
Chalmers University of Technology
Gothenburg
Sweden
Kaarina Lähteenmäki
Finnish Red Cross Blood Service
Helsinki
Finland
Diogo B. Lima
Structural Mass Spectrometry and Proteomics Unit
Institut Pasteur
Paris
France
Nelson Lima
CEB‐Centre of Biological Engineering
Micoteca da Universidade do Minho
University of Minho
Braga
Portugal
Åsa Lindgren
Department of Clinical Microbiology
Sahlgrenska University Hospital
and
Department of Infectious Diseases
Institute of Biomedicine, The Sahlgrenska
Academy, University of Gothenburg
Sweden
Pierre Mahé
bioMérieux SA
Marcy‐l’Etoile
France
Thomas Maier
Bruker Daltonik GmbH
Bremen
Germany
Christian Malosse
Structural Mass Spectrometry and Proteomics Unit
Institut Pasteur
Paris
France
Jaana Mättö
Finnish Red Cross Blood Service
Helsinki
Finland
Mariana Mazza
Department of Mycology
INEI/Instituto Nacional de Enfermedades
Infecciosas “Dr. Carlos G. Malbrán”‐ANLIS.
Ciudad Autónoma de Buenos Aires
Argentina
Raju V. Misra
Genomic Research Unit
Public Health England
London
UK
Hermine V. Mkrtchyan
School of Biological and Chemical Sciences
Queen Mary University of London
UK
Edward R.B. Moore
Department of Clinical Microbiology
Sahlgrenska University Hospital
and
Department of Infectious Diseases
Institute of Biomedicine
The Sahlgrenska Academy
University of Gothenburg
Sweden
Leonardo P. Munoz
Department of Natural Sciences
Middlesex University
London,
UK
Elisabeth Nagy
Institute of Clinical Microbiology Faculty of Medicine
University of Szeged
Hungary
Ali Olkun
Department of Natural Sciences
Middlesex University
London,
UK
Onya Opota
Institute of Microbiology, University
Hospital Center, and University of
Lausanne
Switzerland
Ana Carolina B. Padovan
Department of Medicine Infectious Diseases Section
Federal University of São Paulo (UNIFESP)
SP
Brazil
Nadine Perrot
bioMérieux SA
La Balme‐les‐Grottes
France
Bruno Pot
Applied Maths NV
Sint‐Martens Latem
Belgium
Ian R. Poxton
Department of Medical Microbiology
University of Edinburgh
UK
Guy Prod’hom
Institute of Microbiology, University
Hospital Center, and University of
Lausanne
Switzerland
Christopher Ring
Department of Natural Sciences
Middlesex University
London,
UK
Ilja Ritamo
ThermoFisher Scientific
Vantaa
Finland
Graham Rose
Genomic Research Unit
Public Health England
London
UK
Cledir R. Santos
Department of Chemical Sciences
and Natural Resources
CIBAMA, BIOREN, University of La Frontera
Temuco
Chile
Vlad Serafim
Department of Natural Sciences
Middlesex University
London
UK
Ajit J. Shah
Department of Natural Sciences
Middlesex University
London
UK
Haroun N. Shah
Proteomics Research
Public...
| Erscheint lt. Verlag | 31.3.2017 |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin | |
| Naturwissenschaften ► Chemie ► Analytische Chemie | |
| Technik | |
| Schlagworte | antibiotic resistance of single isolates • antibiotic resistance testing • Antimicrobial Resistance • antimycotic resistance testing • bacterial identification • Biomarker discovery • biomedical scientists • Biowissenschaften • Chemie • Chemistry • Clinical Diagnostic Microbiology • clinical microbiologists • clinical microbiology • detection of antibiotic resistance • detection of biological warfare agents • Detection of Resistance Mechanisms • diagnostic technologists • epidemiological studies • identification of Bacteroides • identification of microorganisms • Identification of Species in Mixed Microbial Populations • identifying Mycobacterium • identify microbes to the species level • Klinische Mikrobiologie • Life Sciences • MALDI technology • MALDI-TOF • MALDI-TOF mass spectrometry • MALDI-ToF MS • Massenspektrometrie • mass spectral database • Mass Spectrometry • Medical Science • Medizin • Microbial DNA Analysis • Microbial Identification • microbial pathogenicity • Mikrobiologie • pathogen detection • Proteogenomics of Non-Model Microorganisms • Proteomics • single strain typing • strain typing • Tandem Mass Spectrometry • tandem MS/MS • top-down proteomics |
| ISBN-13 | 9781118960233 / 9781118960233 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
EPUB (Adobe DRM)Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
